Bay Area Biotech on 12/6 →
Co-Founder and CEO, Wetpaint
Nobel Laureate, Professor of Biology, Caltech
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
VP of Research and Special Initiatives, Google
VP of Research & Policy, Ewing Marion Kauffman Foundation
CEO of Dynamis Corporation
President and CEO of the Central Indiana Corporate Partnership
Partner at New Enterprise Associates
December 5, 2017 ·
December 6, 2017 ·
December 11, 2017 ·
Sponsored · Whitepaper
Reduce turnaround times, cut excessive admin expenses and increas
The business landscape is constantly evolving. Why shouldn’t your company change with it?
The pressure has never been greater for life science organizations to shorten the development cycle for new drugs and devices.
The state’s programs for entrepreneurs made a record-setting impact in 2016.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2017, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.